How to Cite
Abstract
In 29 patients with various malignant tumors there was carried out an estimation of Thiotriazoline efficacy in the treatment of hepatotoxicity in the process of combined chemora-diation therapy. It has been showed that ten-day application of Thiotriazoline in double dose (2,5% solution intravenously by 4,0 ml twice within 24 hours and 1 tablet (100 mg) twice within 24 hours) in patients with I and II degree of hepatotoxicity at the background of combined chemoradiation therapy enabled to remove completely manifestations of cytolysis in 100% of patients, without changing regimen of chemotherapy. To normalize levels of biochemical indices of blood in III degree of hepatotoxicity, more a long intake of Thiotriazoline (about 4 weeks) was required. Regimen of chemoradiation therapy in the period of Thiotriazoline application was not changed.References
Гріднєв О.Є. Перекисне окислення ліпідів і печінка // Сучасна гастроентерол. — 2005. — № 5 — С. 80-83.
Мазур И.А., Волошин И.А., Чекман И.С. и соавт. Тиотриазолин: фармакологические аспекты и клиническое применение // Запорожье. — 2005. — С. 146.
Мазур И.А., Чекман И.С., Беленичев И.Ф. и соавт. Метаболитотропные препараты // Запорожье. — 2007. — С. 309.
Савченкова Л.В., Филатов Д.А., Белоусова И.П. Клиническая фармакология тиотриазолина (обзор литературы) // Украин. мед. альманах. — 2008. — Том 11, — С. 212-217.
Ханевич М.Д., Селиванов Е.А., Фадеев Р.В. и др. Профилактика печеночной недостаточности при расширенных гемигепатэктомиях у больных с первичным раком и метастатическим поражением печени // Хирург. — 2012. — № 3. — С. 9-13.
Field K.M., Dow C., Michael M. Part I: Liver function in oncology: biochemistry and beyond // Lancet Oncol. — 2008. — Vol. 9. — Р 1092-1101.
Floyd J., Mirza I., Sachs B., et al. Hepatotoxicity of chemotherapy // Semin. Oncol. — 2006. — Vol. 33. — Р. 50-67.
Kampfenkel T., Tischoff I., Bonhag H., et al. Chemotherapy-associated steatohepatitis in patients with colorectal cancer and surgery on hepatic metastasis: clinical validation of a histopathological scoring system and preoperative risk assessment // Z. Gastroenterol. — 2011. — Vol. 49. — Р 1407.
King P.D., Perry M.C. Hepatotoxicity of chemotherapy // The Oncologist. — 2001. — Vol. 6. — Р 162-176.
Larrey D. Drug — induced liver diseases // J. Hepatol. — 2000. — Vol. 32. — Р. 77-88.
Tannapfel A., Reinacher-Schick A. Chemotherapy Associated Hepatotoxicity in the treatment of advanced colorectal cancer (CRC) // Z. Gastroenterol. — 2008. — Vol. 46. — Р. 435-440.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...